Yorsua, Mivel .

HRN: 25-74-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2024
CEFUROXIME 1.5GM (VIAL)
08/22/2024
08/23/2024
IV
1.5 G
Q8
Sp 1 LTCS
Waiting Final Action 
08/22/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/22/2024
08/24/2024
IV
500 Mg
Q8
Thickly MSAF
Waiting Final Action 
08/22/2024
METRONIDAZOLE 500MG (TAB)
08/24/2024
08/30/2024
PO
500 Mg
Q8
Thickly MSAF
Waiting Final Action 
08/23/2024
CEFUROXIME 500MG (TAB)
08/23/2024
08/29/2024
PO
500mg
BID
Post Cs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: